课题基金 / 基金详情

项目摘要

项目成果

Walter J Atwood的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The major goal of our type III transitional COBRE is to provide state of the art genomic and transgenic core services to the Brown University community and affiliated centers in the Northeast while preparing to transition to independent suport in the next five years. The scientific theme of the Center developed with type II COBRE support was cancer signaling networks. This general scientific theme will be continued but we as a center are poised to provide the research infrastructure for a wider range of scientific projects than were supported initially in the type II COBRE. The pilot project mechanism associated with the type III COBRE will be used to nucleate collaborative efforts by groups of faculty focusing on significant scientific problems that can immediately translate into multi-PI and/or program project applications. The research cores originally proposed were Mouse Transgenics, Imaging, Genomics and Bioinformatics. The first three carried over from the type I COBRE while the latter was established as a new core facility. The Bioinformatics core was only briefly supported by the type II COBRE as it evolved into an independent center (Center for Computational Molecular Biology). The Imaging core was also graduated from COBRE support and now functions as an independent facility. The imaging core has grown exponentially and is a major resource for investigators at Brown and in the state. We have a track record of using COBRE resources to develop solid research cores whose scientific focus allows them to achieve independence from this mechanism. Our remaining two cores for which we are requesting support are quickly becoming more heavily relied on by the scientific community here in Rhode Island. We will continue to improve these cores to the point where they can be independently supported by a combination of user fees, individual and program-type grant support, and University cost-sharing when needed.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
Functional Assessment In Vivo of the Mouse Homolog of the Human Ala-9-Ser NHE6 Variant.
人 Ala-9-Ser NHE6 变体的小鼠同源物的体内功能评估。
DOI: 10.1523/eneuro.0046-19.2019
发表时间: 2019
期刊: eNeuro
影响因子: 3.4
作者: [Ouyang,Qing, Joesch-Cohen,Lena, Mishra,Sasmita, Riaz,HasibA, Schmidt,Michael, Morrow,EricM]
通讯作者: Morrow,EricM
DOI: 10.1101/gr.183848.114
发表时间: 2015-05
期刊: Genome research
影响因子: 7
作者: [Foulk MS, Urban JM, Casella C, Gerbi SA]
通讯作者: Gerbi SA
DOI: 10.1371/journal.pone.0156676
发表时间: 2016
期刊: PloS one
影响因子: 3.7
作者: [Chen Y, Cossman J, Jayasuriya CT, Li X, Guan Y, Fonseca V, Yang K, Charbonneau C, Yu H, Kanbe K, Ma P, Darling E, Chen Q]
通讯作者: Chen Q
DOI: 10.1002/psc.2731
发表时间: 2015-03
期刊: JOURNAL OF PEPTIDE SCIENCE
影响因子: 2.1
作者: [Yatawara, Achani, Gaidos, Gabriel, Rupasinghe, Chamila N., O'Hara, Bethany A., Pellegrini, Maria, Atwood, Walter J., Mierke, Dale F.]
通讯作者: Mierke, Dale F.
Progressive Multifocal Leukoenephalopathy: Endemic Viruses and Lethal Brain Disease
  • 批准号:
    10393583
  • 项目类别:
  • 资助金额:
    $83.61万
  • 财政年份:
    2020
  • 负责人:
    Walter J Atwood
  • 依托单位:
Progressive Multifocal Leukoenephalopathy: Endemic Viruses and Lethal Brain Disease
  • 批准号:
    10604314
  • 项目类别:
  • 资助金额:
    $83.61万
  • 财政年份:
    2020
  • 负责人:
    Walter J Atwood
  • 依托单位:
CENTER FOR CANCER SIGNALING NETWORKS
  • 批准号:
    8364911
  • 项目类别:
  • 资助金额:
    $113.32万
  • 财政年份:
    2011
  • 负责人:
    Walter J Atwood
  • 依托单位:
Center for Cancer Signaling Networks
  • 批准号:
    8251146
  • 项目类别:
  • 资助金额:
    $109.13万
  • 财政年份:
    2011
  • 负责人:
    Walter J Atwood
  • 依托单位: